Based on 3 analysts giving stock ratings to Phibro Animal Health Corp in the past month.
In the current month, PAHC has received 1 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. PAHC average Analyst price target in the last month is 47.000.
Based on analysts' estimates, PAHC EPS is projected to reach 0.940 in FY2027Q2, following reported EPS of 0.727 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.73, while Phibro Animal Health CorpPAHC's earnings per share (EPS) for the previous quarter was USD 0.54. EPS for the next quarter is expected at USD 0.94.